Alpelisib: A New Hope for Patients with PIK3CA-Mutated Breast Cancer

Breast cancer is the most common cancer among women worldwide, and about 70% of cases are hormone receptor (HR)-positive, meaning that they depend on hormones such as estrogen and progesterone for growth.